Canopus BioPharma's market value is the price at which a share of Canopus BioPharma trades on a public exchange. It measures the collective expectations of Canopus BioPharma Incorporated investors about its performance. Canopus BioPharma is trading at 1.0E-4 as of the 15th of January 2025, a No Change since the beginning of the trading day. The stock's open price was 1.0E-4. With this module, you can estimate the performance of a buy and hold strategy of Canopus BioPharma Incorporated and determine expected loss or profit from investing in Canopus BioPharma over a given investment horizon. Check out Canopus BioPharma Correlation, Canopus BioPharma Volatility and Canopus BioPharma Alpha and Beta module to complement your research on Canopus BioPharma.
Please note, there is a significant difference between Canopus BioPharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Canopus BioPharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Canopus BioPharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Canopus BioPharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Canopus BioPharma's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Canopus BioPharma.
0.00
12/16/2024
No Change 0.00
0.0
In 31 days
01/15/2025
0.00
If you would invest 0.00 in Canopus BioPharma on December 16, 2024 and sell it all today you would earn a total of 0.00 from holding Canopus BioPharma Incorporated or generate 0.0% return on investment in Canopus BioPharma over 30 days. Canopus BioPharma is related to or competes with WK Kellogg, Hooker Furniture, John B, Sysco, AMCON Distributing, and Bridgford Foods. Canopus BioPharma Incorporated, a pharmaceutical research company, provides pharmaceutical products and assay methods to... More
Canopus BioPharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Canopus BioPharma's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Canopus BioPharma Incorporated upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Canopus BioPharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Canopus BioPharma's standard deviation. In reality, there are many statistical measures that can use Canopus BioPharma historical prices to predict the future Canopus BioPharma's volatility.
Canopus BioPharma is out of control given 3 months investment horizon. Canopus BioPharma secures Sharpe Ratio (or Efficiency) of 0.16, which signifies that the company had a 0.16% return per unit of risk over the last 3 months. We were able to collect and analyze data for twenty-seven different technical indicators, which can help you to evaluate if expected returns of 6.67% are justified by taking the suggested risk. Use Canopus BioPharma Mean Deviation of 25.62, risk adjusted performance of 0.129, and Downside Deviation of 52.7 to evaluate company specific risk that cannot be diversified away. Canopus BioPharma holds a performance score of 12 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 0.54, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Canopus BioPharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Canopus BioPharma is expected to be smaller as well. Use Canopus BioPharma jensen alpha, maximum drawdown, semi variance, as well as the relationship between the sortino ratio and potential upside , to analyze future returns on Canopus BioPharma.
Auto-correlation
-0.19
Insignificant reverse predictability
Canopus BioPharma Incorporated has insignificant reverse predictability. Overlapping area represents the amount of predictability between Canopus BioPharma time series from 16th of December 2024 to 31st of December 2024 and 31st of December 2024 to 15th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Canopus BioPharma price movement. The serial correlation of -0.19 indicates that over 19.0% of current Canopus BioPharma price fluctuation can be explain by its past prices.
Correlation Coefficient
-0.19
Spearman Rank Test
0.3
Residual Average
0.0
Price Variance
0.0
Canopus BioPharma lagged returns against current returns
Autocorrelation, which is Canopus BioPharma pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Canopus BioPharma's pink sheet expected returns. We can calculate the autocorrelation of Canopus BioPharma returns to help us make a trade decision. For example, suppose you find that Canopus BioPharma has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
Canopus BioPharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Canopus BioPharma pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Canopus BioPharma pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Canopus BioPharma pink sheet over time.
Current vs Lagged Prices
Timeline
Canopus BioPharma Lagged Returns
When evaluating Canopus BioPharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Canopus BioPharma pink sheet have on its future price. Canopus BioPharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Canopus BioPharma autocorrelation shows the relationship between Canopus BioPharma pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Canopus BioPharma Incorporated.
Regressed Prices
Timeline
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Other Information on Investing in Canopus Pink Sheet
Canopus BioPharma financial ratios help investors to determine whether Canopus Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Canopus with respect to the benefits of owning Canopus BioPharma security.